Pegylated polyethyleneimine macromolecular magnetic resonance imaging contrast agent and preparation method of contrast agent
A technology of polyethyleneimine and magnetic resonance imaging, which is applied in the field of medical imaging contrast agents, can solve the problems of complex structure of polyamidoamine dendrimers, complex synthesis methods of block copolymers, and short blood circulation time, etc. Vascular and tissue imaging quality, improved biocompatibility and blood circulation time, and good practical value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0056] Such as figure 1 PEI-DTPA(GdIII)-mPEG was prepared as indicated.
[0057] 80 mg of PEI (branched, Mw=25,000, purchased from Sigma-Aldrich) was dissolved in 40 mL of water, and 6 mL of an aqueous solution containing 57.1 mg of cDTPAA (purchased from Sigma-Aldrich) was added dropwise under stirring. Stir the reaction at room temperature for 12 hours to obtain an aqueous solution of PEI-DTPA; dialyze the reaction solution, and finally freeze-dry the aqueous solution of the product to obtain PEI-DTPA (108 mg, white solid);
[0058]Weigh 68.6mg of prepared PEI-DTPA, dissolve in 15mL of water, then dissolve 160mg of mPEG-NHS (molecular weight 5000, purchased from Shanghai Xibao Biological Co., Ltd.) in 16mL of water, add dropwise to PEI under magnetic stirring -in an aqueous solution of DTPA, and stirred at room temperature for 15 hours, finally dialyzed the reaction solution, and lyophilized the aqueous solution of the product to obtain PEI-DTPA-mPEG (212mg, white solid); ...
Embodiment 2
[0065] Preparation of PEI-DTPA(Gd III)-mPEG.
[0066] The rest is as shown in Example 1. In the step A: 120 mg of polyethyleneimine (PEI) was dissolved in 60 mL of water, and 9 mL of an aqueous solution containing 85.7 mg of cDTPAA was added dropwise;
[0067] In the step B: 240 mg of mPEG-NHS was dissolved in 24 mL of water, and added dropwise to the aqueous solution of 102.9 mg of PEI-DTPA prepared in step A;
[0068] In the step C: add 15.8 mg of gadolinium trichloride to the aqueous solution of 171.5 mg of PEI-DTPA-mPEG prepared in step B, and stir and react at room temperature for 4 hours to obtain a PEI-DTPA(GdIII)-mPEG aqueous solution, Then add 90 μL of triethylamine and stir for 40 minutes, finally add 60 μL of acetic anhydride, stir for 24 hours, then perform dialysis and freeze-dry to obtain the macromolecular magnetic resonance imaging contrast agent PEI-DTPA (Gd III) of PEGylated polyethyleneimine -mPEG.
Embodiment 3
[0070] T measured by in vitro MR 1 Value to test the MR imaging effect of the material PEI-DTPA(GdIII)-mPEG synthesized in Example 1 and the clinical MR contrast agent gadopentetate meglumine.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com